Prevalence
Causes
Clinical
features
Differential
diagnosis
Investigations
Therapy
Prevention
Prognosis
|  |  | | Investigations |
Consider
-
mast cell tryptase (within 6 hrs of the episode)
d
Consider referral to a specialist clinic for further
investigations, including
-
skin prick testing
d
-
IgE levels d
-
Intradermal testing for drug induced episodes
d
Why?
Mast cell tryptase can rule out anaphylaxis and intradermal testing can
help rule it in
| Patient |
Target Disorder and Reference Standard |
Diagnostic Test |
LR+
(95% CI)
|
Post-test Probability |
LR-
(95% CI)
|
Post-test Probability |
suspected anaphylaxis
d
(pre-test probability: 64%)
|
Drug-induced anaphylaxis (sole agent, positive passive transfer or subsequent
anaesthesia)
|
intradermal testing
|
22
(3.2 to
150)
|
98% |
0.24
(0.17 to
0.35)
|
30% |
suspected anaphylaxis
d
(pre-test probability: 39%)
|
Problematic subsequent general anaesthetic
|
skin-prick or intradermal testing
|
1.2
(1.1 to
1.4)
|
44% |
0.18
(0.04 to
0.76)
|
11% |
suspected anaphylaxis
d
(pre-test probability: 44%)
|
Anaphylaxis (radioimmunoassay or intradermal testing)
|
Mast cell tryptase >3mcg/L
|
4.9
(3.6 to
6.6)
|
79% |
0.066
(0.032 to
0.14)
|
5% |
|